Standard Life Aberdeen »

Intra Cellular Therapies shares owned by Standard Life Aberdeen

Quarter-by-quarter ownership of Intra Cellular Therapies (ITCI) shares owned by Standard Life Aberdeen from 13F filings

Historical chart of Standard Life Aberdeen investment in Intra Cellular Therapies

Tip: Access up to 7 years of quarterly data

All positions including Intra Cellular Therapies held by Standard Life Aberdeen consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intra Cellular Therapies by Standard Life Aberdeen

Quarter filed Position value Share count Share price at filing
2024-12-31 $19M 229k 83.52
2024-09-30 $18M 251k 73.17
2024-06-30 $16M 233k 68.49
2024-03-31 $9.3M 134k 69.20
2023-12-31 $4.2M 59k 71.62

More positions owned by Standard Life Aberdeen

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl C (GOOG)
Broadcom (AVGO)
Meta Platforms Cl A (META)
JPMorgan Chase & Co. (JPM)
Eli Lilly & Co. (LLY)
Visa Com Cl A (V)
Mastercard Incorporated Cl A (MA)
Abbvie (ABBV)
Johnson & Johnson (JNJ)

View all positions for Standard Life Aberdeen

Top funds holding Intra Cellular Therapies

Huntington National Bank

View all funds holding Intra Cellular Therapies